Skip to main content

Obesity Topic Center

Conference Coverage
11/06/2025
Grace Taylor, MS, MA
A study presented at ObesityWeek 2025 shows that adding structured exercise to calorie-restricted weight loss plans significantly increases daily, non-exercise physical activity in older adults with obesity.
A study presented at ObesityWeek 2025 shows that adding structured exercise to calorie-restricted weight loss plans significantly increases daily, non-exercise physical activity in older adults with obesity.
A study presented at ObesityWeek...
11/06/2025
First Report Managed Care
Conference Coverage
11/05/2025
Hannah Musick
A quality improvement initiative demonstrated that partnering with an integrated specialty pharmacy significantly increased GLP-1 RA prescription fulfillment and patient enrollment in a pediatric obesity clinic, streamlining access and...
A quality improvement initiative demonstrated that partnering with an integrated specialty pharmacy significantly increased GLP-1 RA prescription fulfillment and patient enrollment in a pediatric obesity clinic, streamlining access and...
A quality improvement initiative...
11/05/2025
First Report Managed Care
Conference Coverage
11/05/2025
Hannah Musick
Oral bofanglutide demonstrated favorable safety, dose-dependent exposure, and meaningful weight reduction over 14 days, supporting its potential as a once-daily GLP-1 receptor agonist therapy for type 2 diabetes and obesity.
Oral bofanglutide demonstrated favorable safety, dose-dependent exposure, and meaningful weight reduction over 14 days, supporting its potential as a once-daily GLP-1 receptor agonist therapy for type 2 diabetes and obesity.
Oral bofanglutide demonstrated...
11/05/2025
First Report Managed Care
News
11/04/2025
Grace Taylor, MS, MA
A study presented at ObesityWeek by the Veterans Health Administration found that patients with type 2 diabetes taking GLP-1 receptor agonists showed significantly lower rates of unhealthy alcohol use, suggesting potential behavioral benefits...
A study presented at ObesityWeek by the Veterans Health Administration found that patients with type 2 diabetes taking GLP-1 receptor agonists showed significantly lower rates of unhealthy alcohol use, suggesting potential behavioral benefits...
A study presented at ObesityWeek...
11/04/2025
First Report Managed Care
Conference Coverage
11/04/2025
Hannah Musick
In a national cohort study presented at ObesityWeek 2025, GLP-1 receptor agonist use in dialysis patients with type 2 diabetes was associated with lower mortality, greater weight loss, and increased likelihood of transplant waitlisting,...
In a national cohort study presented at ObesityWeek 2025, GLP-1 receptor agonist use in dialysis patients with type 2 diabetes was associated with lower mortality, greater weight loss, and increased likelihood of transplant waitlisting,...
In a national cohort study...
11/04/2025
First Report Managed Care
News
10/21/2024
Lisa Kuhns, PhD, MD
A study published in the International Journal of Obesity found that gastric bypass surgery leads to significant long-term weight loss and metabolic changes, suggesting that maintaining fat-free mass may help sustain metabolic rates...
A study published in the International Journal of Obesity found that gastric bypass surgery leads to significant long-term weight loss and metabolic changes, suggesting that maintaining fat-free mass may help sustain metabolic rates...
A study published in the...
10/21/2024
First Report Managed Care
Conference Coverage
10/15/2024
Hannah Musick
A surge in GLP-1 drug use for weight management in the US has led to decreasing rates of sustained use and meaningful weight loss, as highlighted in a recent study analyzing trends in medication persistence and outcomes.
A surge in GLP-1 drug use for weight management in the US has led to decreasing rates of sustained use and meaningful weight loss, as highlighted in a recent study analyzing trends in medication persistence and outcomes.
A surge in GLP-1 drug use for...
10/15/2024
First Report Managed Care
News
10/08/2024
Jolynn Tumolo
Helicobacter pylori infection may curb the benefit of sleeve gastrectomy in patients with obesity and diabetes, according to a study published in the International Journal of Obesity.
Helicobacter pylori infection may curb the benefit of sleeve gastrectomy in patients with obesity and diabetes, according to a study published in the International Journal of Obesity.
Helicobacter pylori infection...
10/08/2024
First Report Managed Care
News
09/16/2024
Lisa Kuhns, PhD, MD
Obesity is associated with an increased cancer risk in patients with cardiovascular disease (CVD), highlighting the need for targeted prevention strategies, according to study results published in the Journal of the American Heart...
Obesity is associated with an increased cancer risk in patients with cardiovascular disease (CVD), highlighting the need for targeted prevention strategies, according to study results published in the Journal of the American Heart...
Obesity is associated with an...
09/16/2024
First Report Managed Care
News
09/03/2024
Lisa Kuhns, PhD, MD
Obesity, traditionally recognized as a significant public health threat due to its association with numerous metabolic, inflammatory, and psychosocial conditions, is now emerging as a complex factor in the development and progression of...
Obesity, traditionally recognized as a significant public health threat due to its association with numerous metabolic, inflammatory, and psychosocial conditions, is now emerging as a complex factor in the development and progression of...
Obesity, traditionally...
09/03/2024
First Report Managed Care
Industry Insights